Chagas' Disease: Serodiagnosis with Purified Gp25 Antigen

Julio Scharfstein Department of Immunology, Institute of Microbiology, Federal University of Rio de Janeiro

Search for other papers by Julio Scharfstein in
Current site
Google Scholar
PubMed
Close
,
Alejandro Luquetti Department of Pathology, Institute for Tropical Pathology, Federal University of Goiás

Search for other papers by Alejandro Luquetti in
Current site
Google Scholar
PubMed
Close
,
Ana C. M. Murta Department of Immunology, Institute of Microbiology, Federal University of Rio de Janeiro

Search for other papers by Ana C. M. Murta in
Current site
Google Scholar
PubMed
Close
,
Monica Senna Department of Immunology, Institute of Microbiology, Federal University of Rio de Janeiro

Search for other papers by Monica Senna in
Current site
Google Scholar
PubMed
Close
,
Joffre M. Rezende Department of Clinical Medicine, Faculty of Medicine, Federal University of Goiás

Search for other papers by Joffre M. Rezende in
Current site
Google Scholar
PubMed
Close
,
Anis Rassi Department of Clinical Medicine, Faculty of Medicine, Federal University of Goiás

Search for other papers by Anis Rassi in
Current site
Google Scholar
PubMed
Close
, and
Lúcia Mendonça-Previato Department of General Microbiology, Institute of Microbiology, Federal University of Rio de Janeiro

Search for other papers by Lúcia Mendonça-Previato in
Current site
Google Scholar
PubMed
Close
Restricted access

Development of a highly specific test system for the diagnosis of Chagas' disease (CD) was sought using Gp25, a surface glycoprotein recently isolated from Trypanosoma cruzi culture forms. Radioimmunoprecipitation assays were performed to screen 567 sera for IgG antibodies to Gp25. Correct diagnosis was attained in 97.8% of the 321 sera collected from chagasic patients in several endemic areas of South America.

Sera from patients with various clinical forms of chronic disease displayed similar levels of antibodies (Abs) to Gp25. Moreover, there was little cross-reactivity when assayed against 246 sera from non-chagasic individuals, including 105 samples from individuals infected with unrelated trypanosomatids. Cross-reactivity was found in two such sera; these were used to identify a minor protein contaminant as the nonspecific antigen. Residual cross-reactive molecules were eliminated from Gp25 by affinity purification on Concanavalin A (Con A) columns. We recommend this antigen-antibody system for use in routine screening of blood donors.

Author Notes

Save